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Abstract 
Objective: This study examined the influence of cognitive and non-cognitive factors at the time of 
diagnosis on the survival of patients with treated probable Alzheimer Disease (AD). 
Methods: Consecutive patients seen at a regional, tertiary-referral clinic completed a battery of 
cognitive tests and assessments of activities of daily living and neuropsychiatric symptoms. These 
clinic data were linked with death certificate data for all individuals and survival from diagnosis 
was calculated. Cox regression models were constructed using the baseline covariates. 
Results: The sample comprised 653 patients (459 women), mean age 77.1 years (SD 7.6, range 48–
94 years), diagnosed with probable AD and treated with a cholinesterase inhibitor. In the survival 
analysis, age was a consistently significant predictor of survival with a gender-adjusted hazard 
ratio of 1.35 (95% CI 1.23, 1.48) for one standard deviation increase in age. Men were at greater 
risk of death than women (age-adjusted HR 1.44, 95% CI 1.19, 1.73). In a model adjusted for all 
study variables, Paired Associate Learning (CANTAB) and the psychotic factor of the NPI were 
significant predictors of survival.  
Conclusions: At diagnosis, in addition to the anticipated impact of age and gender, the presence of 
psychotic symptoms and poor performance on PAL are also indicators of poor prognosis.  
 
[206 words] 
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Introduction 
The notion that capturing a series of patient characteristics will aid in estimating prognosis is 
appealing for clinicians, patients and their relatives as they plan their future.  With the number of 
cases of dementia increasing rapidly (Ferri, et al. 2005), there is an obvious need to understand 
prognosis in people with this condition. While it is known that mortality in dementia increases 
with the severity of disease (e.g. Andersen et al. 2010), there is a general paucity of data about 
other predictors of survival and conclusions are limited by the difficulties in extrapolating from 
populations to individuals. Apart from the more general effect of delirium on survival in all 
patients (Inouye, et al. 1993), co-morbid medical conditions (Van Dijk, et al. 1996)—particularly 
cerebrovascular and respiratory diseases (Helmer, et al. 2001; Hicks, et al. 2010) but also falls, 
diabetes and cardiovascular disease (Larson, et al. 2004; Mielke, et al. 2007)—and socio-economic 
factors, such as education (Musicco, et al. 2009) have been shown to affect survival in dementia. 
Further potential candidates for predictors of survival in people with dementia have included 
baseline cognitive function (Andersen et al. 2010; Hötte, et al. 2010; Landi, et al. 1999), pre-
morbid cognitive ability (cognitive reserve; Scarmeas, et al. 2006; Stern, et al. 1999), difficulties 
with activities of daily living (ADLs; Agüero-Torres, et al. 1998; Newcomer, et al. 2003) and the 
presence of behavioural and psychological symptoms of dementia (BPSDs; Tun, et al. 2007), 
particularly psychotic symptoms (Scarmeas, et al. 2005).  
 
Therefore, the aim of this study was to examine the influence of cognitive status, ADLs and the 
presence of BPSDs at the time of diagnosis on the survival of patients with treated probable 
Alzheimer disease (AD) seen in a tertiary-referral clinic. The objectives were to identify any 
predictors of survival from the above-mentioned factors. 
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Methods 
Sample 
As described in detail by Starr (2007) and Starr and Lonie (2007a, 2007b, 2008), the sample 
comprises consecutive patients seen at a tertiary-referral memory treatment centre covering the 
Lothian region (Lothian Memory Treatment Centre; LMTC) between February 2000 and July 
2001. Routine assessment data were collected as part of a service evaluation approved by the 
Director of Public Health. Patients were included if they were diagnosed with probable AD—
diagnosis was consensus-based involving two old age psychiatrists, a geriatrician and a 
neuropsychologist using NINCDS-ADRDA criteria (McKhann, et al. 1984)—and commenced 
on a cholinesterase inhibitor (either donepezil or rivastigmine). 
 
Measures 
Patients attending the LMTC completed a battery of seven cognitive tests, shown in box 1. ADLs 
were measured using the instrumental activities of daily living (IADL) and the physical self-
maintenance scales (PSMS; both Lawton and Brody 1969). Patients and carers also completed the 
Neuropsychiatric Inventory (NPI; Cummings, et al. 1994). 
 
Data Linkage 
Permission for data linkage was obtained from the NHS Lothian Caldicott Guardian. The 
Information and Services Division of NHS National Services Scotland linked the data with death 
certificate data from the General Register Office for Scotland, providing date of death and all 
causes mentioned on the death certificate for those who had died. The data supplied did not 
distinguish between immediate, underlying or contributory causes of death. 
 
Prior to the merging of the anonymised dataset with the linked data, Scottish Index of Multiple 
Deprivation (SIMD) ranks were obtained for each individual using their postcode (Scottish 
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Government National Statistics 2009). 
 
Calculation of survival times 
Survival was calculated in months from an estimated assessment date using the patient’s date of 
birth and age when assessed. The earliest and latest possible dates of assessment were calculated, 
giving longest and shortest possible survival times respectively. A middle survival using the 
midpoint of the year or the patient’s date of death, whichever was earlier, was also calculated.  
 
Sensitivity analyses 
In order to test the robustness of conclusions, a number of sensitivity analyses were carried out. 
The younger half of the cohort were assigned the shortest survival (i.e. worst prognosis) and 
compared to the older half who were assigned the longest survival. Similarly, post-hoc, the half 
with lower scores on PAL were compared with the half with higher scores and the half with 
lower scores on the NPI psychotic factor were compared to the half with higher scores. 
Furthermore age x gender interaction was examined in all univariate models. 
 
Confounding 
A potential confounder of survival in dementia is antipsychotic medication use, data for which 
were not available for this cohort, since patients with more BPSD (and therefore higher NPI 
scores) might be more likely to be prescribed antipsychotic medications which might affect their 
survival (Schneider, et al. 2005; Wang, et al. 2005). Therefore, the NPI scores for the cases who 
had cerebrovascular disease mentioned on any part of their death certificate (n=87, 17.3%) were 
compared with those without. 
 
Statistical Analysis 
Data were analysed with the statistical package PASW Statistics version 18.0 (SPSS Inc 2010). All 
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covariates, apart from gender and drugs administered, were continuously scored. Age-adjusted 
univariate hazard ratios for men and women were similar, so data were pooled and gender-
adjusted. The combined sample size was sufficient to detect hazard ratios of 1.31 at 80% power 
or 1.37 at 90% power (both with alpha at 0.05). Median survival times were calculated using the 
Kaplan-Meier method (Kaplan and Meier 1958). Cox regression (Cox 1972) was performed using 
stepwise entry of independent variables at p<0.05 with age and gender forced into all models. 
The predictive capacity of each variable was examined separately. Next, multivariate models with 
the following variables were examined because they capture similar domains: MMSE and NART-
IQ; the standard bedside battery of MMSE and tests of frontal lobe function; PAL and DMTS; 
PSMS and IADL; NPI (patient) and NPI (carer). The three NPI factors were also examined in a 
multivariate model. Subsequently the best predictive model was constructed. Study members with 
missing data were excluded from individual models but all models were re-run with using only 
cases with no missing data and hazard ratios were compared to those using the complete dataset. 
 
Results 
The analysis included 653 patients (459 women), mean age 77.1 years (SD 7.6, range 48–94 
years). All patients were treated with either donepezil (429, 66%) or rivastigmine (224, 34%). By 
the date of record linkage on 8th June 2010 502 patients (77%) had died and data from death 
certificates were available for all of these. Baseline characteristics of the sample are shown in 
table 1. All cognitive tests correlated strongly with each other, as did IADL and PSMS scores. 
NPI scores for patient and carer correlated significantly with each other and with the three 
factors but these factors did not correlate with each other. 
 
Effect estimates did not vary with survival time used (longest, middle or shortest) and so the 
middle survival was used. 
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Median survival was 65 months (IQR 69). Women survived significantly longer than men (71 
months, IQR not calculable, vs 52 months, IQR 63; Log Rank p=0.001) as did those treated with 
donepezil rather than rivastigmine (71 months, IQR 74, vs 54 months, IQR 67; Log Rank 
p=0.021). 
 
There were significant differences in survival between decade age groups (Log Rank  p<0.001). 
Median survival was 91 months for those aged 50-59 (IQR not calculable), 85 months for those 
aged 60-69 (IQR not calculable), 66 months for those aged 70-79 (IQR 65), 53 months for those 
aged 80-89 (IQR 61) and 33 months for those aged 90 or over (IQR 55). 
 
Results of Cox regression models for each variable are shown in table 2. Poorer performance on 
all cognitive tests—apart from DMTS which showed a non-significant trend—was significantly 
associated with worse survival. Higher NPI scores for the patient and carer were associated with 
poorer survival. Of the NPI factors, only the psychotic factor was significantly associated with 
worse survival but the hazard ratio for the mood factor was also elevated. Choice of 
cholinesterase inhibitor did not significantly affect survival but greater deprivation was 
significantly associated with worse survival. 
 
Table 3 shows the results of the multivariate Cox regression models. Age had a consistently 
significant effect on survival with a hazard ratio of 1.33–1.42 in all models per standard deviation 
increase. Gender was significantly associated with survival but became non-significant with an 
attenuated effect in the more-adjusted models. 
 
Both MMSE and NART-IQ were significantly associated with survival but only MMSE remained 
significant when both were included in the model. Entering the standard bedside battery of the 
MMSE and tests of frontal function (Animals and FAS), as recommended by the Mental Welfare 
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Commission for Scotland (2007) for the assessment of dementia, resulted in both MMSE and 
Animals being significant covariates—i.e. higher cognitive function and, specifically, better 
frontal lobe function, were associated with better survival. PAL remained a significant predictor 
of survival in a model with PAL and DMTS entered into it. Entering the three significant 
cognitive tests (MMSE, Animals and PAL) or indeed all the cognitive tests conducted identified 
PAL as a consistently significant covariate, i.e. a higher PAL score was associated with better 
survival. 
 
Of the measures of ADLs, IADL was significantly associated with survival but became non-
significant when the patient’s NPI score was included in a model. The patient’s NPI score was 
significantly associated with survival but the carer’s NPI score was not. Deprivation, measured by 
SIMD, was a significant predictor of survival in a univariate model but not in any multivariate 
model. Examining individual NPI factors (mood, psychotic, frontal) identified the psychotic 
factor as the only significant covariate. In a fully-adjusted model the PAL and NPI psychotic 
factor remained significant predictors of survival. 
 
The sensitivity analyses did not affect the results. There was little evidence of age x gender 
interaction following formal testing. Re-running all models using only cases with no missing data 
(n=235) gave similar results but the effect of gender was attenuated (age-adjusted HR male 
gender 1.17, 95% CI 0.84, 1.62, p=0.35). Characteristics of individuals with missing data and the 
non-missing dataset are shown in table 4. 
 
Table 5 shows the causes of death recorded on the patient’s death certificates classified into 
categories adapted from Thomas et al. (1997). There were no differences between men and 
women apart from the general categories of ‘other disease’ (t=-2.0, df=333.5, p=0.05) and 
‘senility’ (t=-3.1, df=603.3, p=0.002) but the former is a heterogeneous category and there were 
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very few instances of men dying with ‘senility’ recorded on their death certificate (n=4, 2.5%). 
Therefore cause of death data for men and women were analysed together. 159 patients (31.7% 
deceased individuals) had pneumonia recorded as a cause of death and 36 (7.2%) senility or a 
similar non-specific category. 111 patients (22.2%) had cardiac disease and 45 (9.0%) had other 
vascular disease recorded on their death certificates.  
 
Rates of all recorded categories of causes of death are higher than the rates for all deaths in 2009 
in Lothian apart from neoplasms (rates for dementia, ‘other vascular disease’ and ‘senility’ were 
not available from data from the General Register Office for Scotland, 2009; similarly it was not 
possible to calculate a meaningful category of ‘other disease’ from available data). Hospital 
discharge data (SMR 01) estimate the crude prevalence of coronary heart disease in the over-75s 
to be 16.1% in Lothian (22.3% M, 12.3% F; ISD Scotland 2011) suggesting a slightly higher rate 
of cardiovascular disease in the females in this cohort with probable AD than the general female 
population. 
 
Comparing individuals who died with cerebrovascular disease mentioned on their death 
certificate (n=87, 17.3%) revealed no significant differences in mean overall NPI scores, factor 
scores or relevant individual items (agitation, aggression, hallucinations or delusions) for which 
antipsychotics might be prescribed. This suggests that antipsychotic-related mortality has not 
confounded the results. 
 
Discussion 
The main finding of this study was that, in addition to increasing age and male gender, a lower 
score on PAL and the presence of psychotic symptoms at baseline were associated with 
significantly worse survival.  Survival was consistently approximately 33-42% worse per standard 
deviation increase in age at baseline in all models. Women survived longer in this study, as has 
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been often shown in dementia (e.g. Doody, et al. 2005; Sinforiani, et al. 2010; Stern, et al. 1997) 
but not Brookmeyer et al. 2002), but the effect of gender became non-significant in models 
including more variables. Gambassi et al. (1999) have suggested that their observed gender-
differences in mortality might result from different levels of comorbidity but, few gender-
differences in causes of death were observed. 
 
Predictors of survival 
In this highly selected, tertiary-referral clinic sample, median overall survival was 65 months (5.4 
years) and median survival by age-group was: 50-59—91 months (7.6 years), 60-69—85 months 
(7.1 years), 70-79—66 months (5.5 years), 80-89—53 months (4.4 years) and over 89—33 
months (2.8 years). 
 
Overall survival in this sample was slightly longer than the 4.9 years reported by Doody et al. 
(2005)—despite the wide recruitment strategy used in that study—and much longer than the 3.1 
years reported from the Canadian Study of Health and Aging (Wolfson, et al. 2001), even though 
they estimated survival from onset of symptoms. Tsai et al. (2007) found a mean survival of 4.5 
years in their memory clinic sample in China, though their AD death rate was only 28.9% 
compared to 77% in the current sample.  
 
Rait et al. (2010) reported a comparable median survival for 60-69 year olds of 6.7 years (vs 7.1 
years in this study) despite using a primary care sample rather than a tertiary-referral sample. 
However, excluding untreated patients from our analysis would be expected to bias the results 
towards prolonged survival. Furthermore, treatment itself is unlikely to be associated with poorer 
survival. 
 
In the present study baseline cognitive function, measured by MMSE, categorical verbal fluency 
Accepted for publication in the International Journal of Geriatric Psychiatry 
 11 
(Animals) and PAL, predicted survival in this clinic sample of people with AD. However in a 
model containing all the cognitive tests, PAL was the only significant predictor of survival. 
Prospective (Andersen et al. 2010; Hötte et al. 2010; Tsai et al. 2007) and retrospective studies 
(Landi et al. 1999) have found that baseline cognitive function—either measured by MMSE or 
severity of dementia—was significantly associated with increased mortality. However Reisberg et 
al. (1996) found that mortality was not related to baseline dementia severity. 
 
NART-IQ has been shown by McGurn et al. (2004), using a sample from this treatment centre, 
to be a reliable measure of pre-morbid full scale IQ in patients with dementia and therefore 
serves as a putative index of cognitive reserve (Richards and Deary 2005; Stern 2006; Stern 2009; 
Whalley, et al. 2004). NART-IQ was significantly associated with survival in a model including 
age and gender—in this study individuals with lower estimated premorbid IQ declined more 
rapidly after diagnosis in contrast to the cognitive reserve hypothesis (Scarmeas et al. 2006; Stern 
et al. 1999). However NART-IQ did not remain significant when MMSE was included in the 
model.  
 
Both IADL and the patient’s NPI score predicted survival in this sample. However IADL 
became non-significant when further variables were included and the NPI psychotic factor was 
the only element which significantly predicted survival. Newcomer et al. (2003) found that 
requiring maximum help in ADLs was associated with worse survival; this effect increased with 
the numbers of activities requiring assistance. Agüero-Torres et al. (1998) found that those who 
functioned worse declined faster. Miller et al. (2011), in the CATIE-AD trial, found that 
preserved ADLs were protective for nursing home admission, though they did not report 
predictors of survival.  
 
Tun et al. (2007) found that survival was significantly lower in AD patients with more BPSD. 
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Sinforiani et al. (2010) also found that higher NPI score at baseline was associated with earlier 
loss of autonomy. Scarmeas et al. (2005) reported that delusions and hallucinations were 
associated with faster decline, both in cognition and function, and that hallucinations were 
associated with increased mortality.  
 
Causes of death 
Bronchopneumonia is commonly reported in people dying with dementia (Morgan and Clarke 
1995), up to 70.9% in presenile AD (Thomas et al. 1997). Table 5 shows a lower rate of 
pneumonia at death suggesting that other age-related causes of death might be more important in 
a late-onset dementia sample compared with patients with early-onset disease.  
 
High rates of cerebrovascular disease and diabetes at death confirm the importance of 
cardiovascular risk factors, particularly diabetes, in the natural history of AD (Knopman, et al. 
2001; Luchsinger, et al. 2005; Solfrizzi, et al. 2004; Whitmer, et al. 2005). The high rate of falls 
suggests that impaired mobility may be an important factor in the later stages of the disease. 
Indeed Buchner and Larson (1987) found a very high fracture rate (15%) in a sample of patients 
with AD.  
 
Limitations 
The assessment battery used in this clinic is likely to be more extensive than that used elsewhere 
in the UK though the treatment protocol will have been similar. Lothian has less of an ethnic mix 
than average in the UK but there it provides a stable population, with migration particularly low 
in this age group. 
 
Since the data were collected for a service evaluation—and not for research purposes—they do 
present limitations and the date of assessment had to be estimated from the patient’s date of 
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birth and their age when assessed, as described above. However there were no differences in 
effect estimates when the longest or shortest possible survival times were used so a midpoint date 
of assessment was used to calculate survival. 
 
Sensitivity analyses examining the effects of assigning worse survival to younger individuals, 
those with higher PAL scores and fewer psychotic symptoms did not alter the results. 
Furthermore there was no evidence of age  x gender interaction. 
 
Details of prescribed medication were not available but increased mortality related to 
antipsychotic medication (Schneider et al. 2005; Wang et al. 2005), as mentioned above, does not 
seem to have confounded the results. However individuals with higher NPI scores—for whom 
these medications might be prescribed—did not have an excess of cerebrovascular disease. 
 
Cardiovascular disease and other risk factors, such as smoking, obesity and individual socio-
economic status (as opposed to the area-based measure used here) are extremely important in 
dementia survival. The absence of these variables is a limitation of this study but since the clinic 
served the whole region of Lothian, there is likely to have been a wide spread of these risk 
factors, as shown by the range of SIMD ranks, and so confounding can be assumed to be 
minimal. 
 
While the sample is specific for patients with treated probable AD it has, by definition, excluded 
patients with other dementias and patients with untreated AD. The implications for survival of 
using a treated sample have been discussed above. In addition, it should be mentioned that this 
study does not allow us to comment on severe dementia since few patients had a baseline MMSE 
of lower than 12 (n=54, 12.9%), in line with trial data and guidelines at the time. 
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Recording of causes of death on death certificates is widely acknowledged to be less than 
completely accurate, particularly for dementia (Martyn and Pippard 1988; Morgan and Clarke 
1995). This is confirmed in this study since only 359 (71.5% of deceased) patients had dementia 
entered onto their death certificate. It is likely that other diseases are also under-reported, perhaps 
not to the same extent, but this is impossible to estimate. 
 
The comparison data are based on all deaths—since this was the only data available—but 79.5% 
deaths in Scotland in 2009 were over-65s (General Register Office for Scotland 2009) and the 
majority of the outcomes are age-related diseases. Proportions of over-65s in death data were 
similar for all areas covered by the LMTC.  
 
Conclusion 
In addition to the anticipated impact of age and gender, the presence of psychotic symptoms and 
poor performance on PAL at baseline are also indicators of poor prognosis.  
 
These clinic-based data indicate that at diagnosis, clinicians should not be optimistic or 
pessimistic about prognosis according to most measures of current cognitive status, pre-morbid 
mental ability, or current functional abilities, or the presence of other BPSDs. Age is a useful 
predictor of survival, with those over 90 years surviving less than three years on average. 
Common causes of death in people with AD were cardiovascular disease (in women) and falls: 
these represent opportunities at diagnosis for prevention to improve survival. 
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Text Box 1: Cognitive Battery in the present sample1 
Cognitive Test Reference Comments 
National Adult Reading Test 
(NART-IQ) 
(Nelson, 1982) The patient is asked to read aloud a list of 
fifty irregularly-pronounced words. McGurn 
et al. (2004) validated this test as an estimate 
of premorbid full-scale IQ in a subgroup of 
this cohort. Higher score = more able. 
Mini-Mental State 
Examination (MMSE) 
(Folstein, et al. 
1975) 
Tests a broad range of cognitive domains and 
scored out of 30. Higher score = more able. 
Hopkins Verbal Learning Test 
(Hopkins) 
(Brandt 1991) The total score of three trials of free recall 
were used from this test of recent verbal 
memory/new learning ability. Higher score = 
more able. 
Category (Semantic) Fluency 
(Animals) 
(Lezak 2004) This common test of executive function also 
tests semantic memory. The patient is asked 
to name as many animals (or fruit or 
vegetables or any other category) as possible 
in a minute. Higher score = more able. 
Lexical Verbal Fluency (FAS) (Lezak 2004) Similar to category fluency but with the extra 
demand of set-shifting. The patient is asked 
to name as many words as possible beginning 
with the letter F (and then A and then S) in 
one minute. Higher score = more able. 
Paired Associate Learning 
(PAL)  
(Robbins, et al. 
1994) 
Subtest from the Cambridge Automated 
Neuropsychological Test Assessment Battery 
(CANTAB) of visual and working memory. 
Higher score = more able. 
Delayed Matching to Sample 
(DMTS) 
(Robbins et al. 
1994) 
Subtest from the CANTAB visual and 
working memory battery. Higher score = 
more able. 
1 previously described in Starr (2007) and Starr and Lonie (2007b) 
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Table 1: Baseline characteristics of the present sample 
Test1 n median IQR Range 
MMSE 621 20 8 0–30 
NART-IQ 351 107 15 0–128 
Hopkins 596 9 6 0–32 
Animals 599 7 5 0–24 
FAS 599 20 18 0–67 
PAL 456 4 3 0–17 
DMTS 443 11 4 0–19 
IADL 546 16 10 0–30 
PSMS 543 7 3 0–23 
NPI (patient) 551 11 14 0–67 
NPI (carer) 550 5 9 0–56 
SIMD Rank 613 4306 3944 51–6504 
1 MMSE, Mini-Mental State Examination; NART-IQ, Estimated IQ using the National Adult 
Reading Test; Hopkins, Hopkins Verbal Learning Test; Animals, Category (Semantic) Fluency—
naming animals; FAS, Lexical Verbal Fluency using the letters F, A & S; PAL, Paired Associate 
Learning from CANTAB; DMTS, Delayed Match to Sample from CANTAB; IADL, 
Instrumental Activities of Daily Living scale; PSMS, Personal Self-maintenance scale; NPI, 
Neuropsychiatric Inventory; SIMD, Scottish Index of Multiple Deprivation 
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Table 2: Age- and gender-adjusted univariate hazard ratios for the relation between study participant 
characteristics and mortality   
Model1 Deaths N HR3 95% CI P 
MMSE 471 621 1.32 1.21, 1.44 <0.001 
NART-IQ 264 351 1.13 1.01, 1.28 0.038 
Hopkins 449 596 1.31 1.19, 1.45 <0.001 
Animals 454 599 1.30 1.18, 1.44 <0.001 
FAS 454 599 1.26 1.14, 1.39 <0.001 
PAL 339 456 1.34 1.19, 1.50 <0.001 
DMTS 328 443 1.11 1.00, 1.23 0.062 
IADL 422 546 1.17 1.06, 1.30 0.002 
PSMS 421 543 1.17 1.06, 1.28 0.002 
NPI (patient) 430 551 1.20 1.09, 1.32 <0.001 
NPI (carer) 428 550 1.12 1.03, 1.23 0.013 
NPI mood 
factor 
225 358 1.07 0.93, 1.22 0.38 
NPI psychotic 
factor 
225 358 1.18 1.04, 1.34 0.010 
NPI frontal 
factor 
225 358 0.99 0.86, 1.13 0.84 
Drug2 502 653 1.09 0.90, 1.32 0.39 
SIMD rank 472 613 1.11 1.01, 1.21 0.028 
1 MMSE, Mini-Mental State Examination; NART-IQ, Estimated IQ using the National Adult 
Reading Test; Hopkins, Hopkins Verbal Learning Test; Animals, Category (Semantic) Fluency—
naming animals; FAS, Lexical Verbal Fluency using the letters F, A & S; PAL, Paired Associate 
Learning from CANTAB; DMTS, Delayed Match to Sample from CANTAB; IADL, 
Instrumental Activities of Daily Living scale; PSMS, Personal Self-maintenance scale; NPI, 
Neuropsychiatric Inventory; SIMD, Scottish Index of Multiple Deprivation 
2 Categorical variable: whether patient received donepezil (reference) or rivastigmine 
3 Hazard ratios, computed using Cox regression analysis, are for one standard deviation disadvantage, 
apart from drug given 
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Table 3: Hazard ratios for the relation of study participant characteristics with mortality (analyses are 
stepwise conditional entry with age and gender forced into the models as established risk factors for 
survival in dementia) 
Model1  Deaths N  p  HR2 (95% CI)  Variables included in the model 
but statistically non-significant 
(p > 0.05) 
Age  502 653  <0.001  1.35 (1.23, 1.48)  
—  
Male Gender     <0.001  1.44 (1.19, 1.73)  
Age 471 621  <0.001  1.37 (1.24, 1.51)  
—  Male Gender   <0.001 1.43 (1.18, 1.74) 
MMSE   <0.001  1.32 (1.21, 1.44) 
Age 264 351  <0.001  1.42 (1.24, 1.63)  
— Male Gender   0.059 1.29 (0.99, 1.68) 
NART-IQ   0.038  1.13 (1.01, 1.28) 
Age 263 350 <0.001 1.38 (1.20, 1.58) 
NART-IQ (p=0.39) Male Gender   0.098 1.25 (0.96, 1.63) 
MMSE   <0.001 1.32 (1.17, 1.48) 
Age 453 598  <0.001  1.33 (1.21, 1.48)  
— 
Male Gender   <0.001 1.42 (1.17, 1.74) 
MMSE   0.008 1.17 (1.04, 1.32) 
Animals   0.004  1.19 (1.06, 1.35) 
Age 453 598  <0.001  1.36 (1.23, 1.50)  
— 
Male Gender   <0.001 1.46 (1.19, 1.78) 
MMSE   0.002 1.21 (1.07, 1.36) 
FAS   0.042  1.13 (1.00, 1.27) 
Age 450 592  <0.001  1.32 (1.20, 1.46)  
FAS (p=0.30) 
Male Gender   <0.001 1.45 (1.19, 1.77) 
MMSE   0.005 1.18 (1.05, 1.33) 
Animals   0.004  1.19 (1.06, 1.34) 
Age 308 419 <0.001 1.33 (1.18, 1.51) 
DMTS (p=0.23) Male Gender   0.024 1.32 (1.04, 1.69) 
PAL   <0.001 1.36 (1.20, 1.53) 
Age 335 451 <0.001 1.35 (1.20, 1.52) 
MMSE (p=0.11) 
Animals (p=0.055) 
Male Gender   0.014 1.34 (1.06, 1.69) 
PAL   <0.001 1.34 (1.19, 1.50) 
Age 338 455 <0.001 1.33 (1.18, 1.49) 
MMSE (p=0.056) Male Gender   0.013 1.34 (1.06, 1.69) 
PAL   <0.001 1.34 (1.20, 1.51) 
Table 3 continues on the next page
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Table 3 continued 
Age 205 278 <0.001 1.39 (1.19, 1.62) MMSE (p=0.12), NART-IQ 
(p=0.69), Animals (p=0.12), 
FAS (p=0.18), Hopkins 
(p=0.11), DMTS (p=0.60) 
Male Gender   0.28 1.18 (0.87, 1.60) 
PAL   <0.001 1.35 (1.17, 1.57) 
Age 421 543 <0.001 1.39 (1.25, 1.55) 
PSMS (p=0.26) Male Gender   <0.001 1.51 (1.23, 1.86) 
IADL   <0.001 1.18 (1.07, 1.30) 
Age 428 549 <0.001 1.42 (1.28, 1.58) 
NPI (carer) (p=0.50) Male Gender   0.001 1.42 (1.16, 1.74) 
NPI (patient)   <0.001 1.20 (1.09, 1.32) 
Age 472 613 <0.001 1.39 (1.26, 1.53) 
— Male Gender   <0.001 1.43 (1.18, 1.74) 
SIMD   0.028 1.11 (1.01, 1.21) 
Age 270 353  <0.001  1.42 (1.23, 1.63)  
IADL (p=0.83) 
SIMD (p=0.66) 
Male Gender   0.038 1.32 (1.02, 1.71) 
NPI (patient)   0.003 1.21 (1.07, 1.36) 
PAL   <0.001  1.35 (1.18, 1.54) 
Age 225 295 <0.001 1.37 (1.17, 1.61) 
NPI mood factor (p=0.42) 
NPI frontal factor (p=0.83) 
Male Gender   0.16 1.23 (0.92, 1.63) 
NPI psychotic factor  0.010 1.18 (1.04, 1.34) 
Age 175 236  0.001  1.39 (1.15, 1.67)  
Animals (p=0.14) 
IADL (p=0.88) 
NPI (patient) (p=0.25) 
Male Gender   0.39 1.15 (0.83, 1.60) 
PAL   0.007 1.25 (1.06, 1.47) 
NPI psychotic factor  0.012  1.21 (1.04, 1.40) 
1 MMSE, Mini-Mental State Examination; NART-IQ, Estimated IQ using the National Adult 
Reading Test; Hopkins, Hopkins Verbal Learning Test; Animals, Category (Semantic) Fluency—
naming animals; FAS, Lexical Verbal Fluency using the letters F, A & S; PAL, Paired Associate 
Learning from CANTAB; DMTS, Delayed Match to Sample from CANTAB; IADL, 
Instrumental Activities of Daily Living scale; PSMS, Personal Self-maintenance scale; NPI, 
Neuropsychiatric Inventory; SIMD, Scottish Index of Multiple Deprivation 
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Table 4: Comparison of the characteristics of patients with complete data and those with missing 
data 
Variable1 
No missing data 
 (N=235) 
Missing data 
 (N=418) 
p 
Age (mean, sd) 78.0 (6.6) 76.6 (8.1) 0.023 
Female (%) 70.2 70.3 0.97 
Donepezil use (%) 64.7 66.3 0.68 
MMSE (mean, sd) 20.6 (4.7) 18.5 (6.3) <0.001 
NART-IQ (mean, sd) 106.9 (10.2) 99.9 (28.4) 0.011 
Hopkins (mean, sd) 10.2 (5.0) 8.7 (4.7) <0.001 
Animals (mean, sd) 8.8 (4.4) 7.2 (4.1) <0.001 
FAS (mean, sd) 24.7 (13.7) 20.4 (12.4) <0.001 
PAL (mean, sd) 4.4 (1.8) 4.1 (1.8) 0.024 
DMTS (mean, sd) 11.4 (2.6) 10.8 (3.5) 0.024 
IADL (mean, sd) 14.8 (6.3) 16.6 (6.5) 0.001 
PSMS (mean, sd) 7.4 (2.7) 8.3 (3.3) 0.001 
NPI (patient) (mean, sd) 12.6 (11.7) 13.9 (11.3) 0.173 
NPI (carer) (mean, sd) 6.1 (6.6) 7.4 (7.4) 0.033 
NPI mood factor (mean, sd) -0.2 (0.98) 0.11 (1.10) 0.39 
NPI psychotic factor (mean, sd) 0.01 (1.02) -0.01 (0.96) 0.89 
NPI frontal factor (mean, sd) 0.02 (1.07) -0.05 (0.69) 0.62 
SIMD Rank (mean, sd) 4067.0 (1965.8) 3984.7 (2006.4) 0.62 
1 MMSE, Mini-Mental State Examination; NART-IQ, Estimated IQ using the National Adult 
Reading Test; Hopkins, Hopkins Verbal Learning Test; Animals, Category (Semantic) Fluency—
naming animals; FAS, Lexical Verbal Fluency using the letters F, A & S; PAL, Paired Associate 
Learning from CANTAB; DMTS, Delayed Match to Sample from CANTAB; IADL, 
Instrumental Activities of Daily Living scale; PSMS, Personal Self-maintenance scale; NPI, 
Neuropsychiatric Inventory; SIMD, Scottish Index of Multiple Deprivation 
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Table 5: Causes of death recorded on death certificates in the present sample by gender 
 
Male  
(n=160, 82.5%) 
 
Female  
(n=342, 74.5%) 
 
Cause n1 %2 
% Lothian 
deaths (2009)3 
n1 %2 
% Lothian 
deaths (2009)3 
Dementia 116 72.5 – 243 71.1 – 
Pneumonia 54 33.8 2.8 105 30.1 4.0 
Cardiac disease 35 21.9 20.9 76 22.2 15.9 
Cerebrovascular disease 31 19.4 7.4 73 21.3 11.0 
Neoplasms 21 13.1 31.7 37 10.8 27.6 
Other vascular disease 15 9.4 – 30 8.8 – 
‘Senility’  
or other general term 
4 2.5 – 32 9.4 – 
Falls 7 4.4 1.0 19 5.6 1.8 
Diabetes 7 4.4 0.9 15 4.4 1.1 
Hip fracture 4 2.5 _ 18 5.3 _ 
Other disease 58 36.3 – 102 29.8 – 
1 Number of deceased individuals from present sample with each cause mentioned on their death 
certificate 
2 Percentages of causes of death for all deceased individuals add up to more than 100 because 
multiple causes were recorded for each individual 
3 Lothian data are for all 2009 deaths from General Register Office for Scotland (2009)—data 
only available for routinely reported categories 
